Our Role

JPG communicates with Government, NHS organisations, regulators and research bodies on key issues that could impact future life sciences investment in the UK.

Within our constitution the JPG aims;

To fully represent the views of Japanese life sciences companies in the UK

To promote Japanese commitment to involvement in healthcare in the UK

To shape the attitudes of Japanese parent companies to encourage investment and business in the UK

To foster communications between the Japanese Pharmaceutical Manufacturers Association (JPMA) and the Association of the British Pharmaceutical Industry (ABPI) and the Government

Our purpose as a group is to

• Provide networking opportunities for members to discuss shared challenges
• Develop and communicate shared positions on key UK policies that impact Japanese pharmaceutical companies, spanning research through to commercialisation
• Enhance and facilitate relationships between company HQs, the Japanese Embassy and UK officials
• Provide a forum for two-way communication between the ABPI Board and Japanese Pharmaceutical Companies